| EMT | Epithelial–mesenchymal transition |
| CP | Cisplatin |
| ROS | Reactive oxygen species |
| DOX | Docetaxel |
| NPs | Nanoparticles |
| AMPK | AMP-activated protein kinase |
| lncRNA | Long non-coding RNAs |
| TAMs | Tumor associated macrophages |
| GC | Gastric cancer |
| OSCC | Oral squamous cell carcinoma |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| SIRT1 | Sirtuin 1 |
| MSI2 | Musashi RNA-binding protein 2 |
| FHL | Four-and-half LIM domain |
| TGF | Tumor growth factor |
| YAP1 | Yes-associated protein 1 |
| TAZ1 | Tazaffin |
| CRC | Colorectal cancer |
| UBE2O | Ubiquitin-conjugating enzyme E2O |
| mTOR | Mammalian target of rapamycin |
| TKI | Tyrosine kinase inhibitor |
| PTX | Paclitaxel |
| Cams | Classically activated macrophages |
| HCC | Hepatocellular carcinoma |
| CCL20 | Chemokine ligand 20 |
| CCR6 | Chemokine receptor 6 |
| EMP3 | Epithelial membrane protein 3 |
| NPC | Nasopharyngeal carcinoma |
| EBV | Epstein-Barr virus |
| PTP1B | Protein tyrosine phosphatase 1B |
| CSCs | Cancer stem cells |
| NSCLC | Non-small cell lung cancer |
| CIP2A | Cancerous inhibitor of protein phosphatase 2A |
| PP2A | Protein phosphatase 2A |
| PPI | Polyphyllin I |
| PPVII | Polyphyllin VII |
| PRS | Paris polyphylla |
| MM | Malignant mesothelioma |
| HOXA3 | Homeobox A3 |
| FOXC2 | Forkhead box protein C2 |
| FOX | Forkhead box |
| PKCα | Protein kinase Cα |
| UCA1 | Urogenital carcinoma antigen 1 |
| SIK2 | Salt inducible kinase 2 |
| VEGF | Vascular endothelial growth factor |
| PD-L1 | Programmed death-ligand 1 |
| MDM2 | Mouse double minute 2 homolog |
| ZCCHC10 | Zinc finger CCHC-type containing 10 |
| NF-κB | Nuclear factor-κB |
| IKKβ | Inhibitor of NF-κB kinase subunit β |
| Mcl-1 | Myeloid cell leukemia 1 |
| NCTD | Norcantharidin |
| DDR | DNA damage response |
| CTGF | Connective tissue growth factor |
| CYR61 | Cysteine rich angiogenic factor 61 |
| PDCD4 | Programmed cell death 4 |
| elF4E | Eukaryotic translation initiation factor 4E |
| MDR1 | Multidrug resistance protein 1 |
| LAMB3 | Laminin subunit β-3; |
| ZEB | Zinc-finger E-box binding homeobox |
| ERCC1 | Excision repair cross-complementary gene 1 |
| ABCG2 | ATP-binding cassette subfamily G member 2 |
| elF5A2 | Eukaryotic initiation factor 5A2 |
| DUBs | Deubiquitinating enzymes |
| USP37 | Ubiquitin specific peptidase 37 |
| Hh | Hedgehog |
| ATM | Ataxia telangiectasia mutated |
| GDF15 | Growth differentiation factor 15 |
| HIF-α, | Hypoxia inducible factor-α |
| COX-2 | Cyclooxygenase-2 |
| PDC | Pyruvate dehydrogenase complex |
| PDK1 | Pyruvate dehydrogenase kinase 1 |
| EGFR | Epidermal growth factor receptor |
| IGF1R | Insulin-like growth factor 1 |
| HOXA11-AS | Homeobox A11 antisense RNA |
| ACTN4 | Actinin alpha 4 |
| LUAD | Lung adenocarcinoma |
| BCL9 | B-cell lymphoma 9 |
| RKIP | Raf kinase inhibitor protein |
| FAT10 | HLA-F adjacent transcript 10 |
| H2A Z | H2A histone family member Z |
| ABC | ATP-binding cassette |
| P-gp | P-glycoprotein |
| MSDs | Membrane spinning domains |
| NBDs | Nucleotide binding domains |
| BBB | Blood–brain barrier |
| BTB | Blood–testis barrier |